نتائج البحث - "Sánchez-Bursón, Juan"

1

دورية أكاديمية

The complex HLA-E-nonapeptide in Behçet disease

مصطلحات موضوعية: Behçet disease, gene association, classical HLA Class I molecules, HLA-E, NK cells

العلاقة: Publisher's version; Sí; Frontiers in Immunology 10: 1080047 (2023); http://hdl.handle.net/10261/352302Test

الإتاحة: https://doi.org/10.3389/fimmu.2023.1080047Test
http://hdl.handle.net/10261/352302Test

View record in BASE

النص الكامل

2

دورية أكاديمية

Efficacy and Safety of Ixekizumab in the Treatment of Radiographic Axial Spondyloarthritis: Sixteen-Week Results From a Phase III Randomized, Double-Blind, Placebo-Controlled Trial in Patients With Prior Inadequate Response to or Intolerance of Tumor Necrosis Factor Inhibitors

المؤلفون: Deodhar, Atul, Poddubnyy, Denis, Pacheco-Tena, Cesar, Salvarani, Carlo, Lespessailles, Eric, Rahman, Proton, Järvinen, Pentti, Sanchez-Burson, Juan, Gaffney, Karl, Lee, Eun Bong, Krishnan, Eswar, Santisteban, Silvia, Li, Xiaoqi, Zhao, Fangyi, Carlier, Hilde, Reveille, John D

المساهمون: Deodhar, Atul, Poddubnyy, Deni, Pacheco-Tena, Cesar, Salvarani, Carlo, Lespessailles, Eric, Rahman, Proton, Järvinen, Pentti, Sanchez-Burson, Juan, Gaffney, Karl, Lee, Eun Bong, Krishnan, Eswar, Santisteban, Silvia, Li, Xiaoqi, Zhao, Fangyi, Carlier, Hilde, Reveille, John D

مصطلحات موضوعية: ankylosing spondyliti, axial spondyloarthriti, ixekizumab, radiographic

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30343531; info:eu-repo/semantics/altIdentifier/wos/WOS:000464454700013; volume:71; issue:4; firstpage:599; lastpage:611; numberofpages:13; journal:ARTHRITIS & RHEUMATOLOGY; http://hdl.handle.net/11380/1167256Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85060108324; http://onlinelibrary.wiley.com/journal/10.1002Test/(ISSN)2326-5205

الإتاحة: https://doi.org/10.1002/art.40753Test
http://hdl.handle.net/11380/1167256Test

View record in BASE

3

مؤتمر

AB0377 CLINICAL SIMILARITY OF ABP 710 WITH INFLIXIMAB (REFERENCE PRODUCT) IN SUBJECTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS

المؤلفون: Genovese, Mark C., Sanchez-Burson, Juan, Oh, Myungshin, Balázs, éva, Neal, Jeffrey, Fanjiang, Gary, Cohen, Stanley

المصدر: Abstracts Accepted for Publication

الإتاحة: https://doi.org/10.1136/annrheumdis-2019-eular.4928Test

View record in BASE

4

مؤتمر

AB0458 A PHASE II RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF OF CONCEPT STUDY OF ORAL SELETALISIB IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME (PSS)

المصدر: Abstracts Accepted for Publication

الإتاحة: https://doi.org/10.1136/annrheumdis-2019-eular.4887Test

View record in BASE

5

مؤتمر

AB0416 A COMPARATIVE STUDY TO ASSESS THE EFFICACY, SAFETY, AND IMMUNOGENICITY OF YLB113 AND ETANERCEPT REFERENCE PRODUCT FOR THE TREATMENT OF PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS

المؤلفون: Yamanaka, Hisashi, Kamatani, Naoyuki, Tanaka, Yoshiya, Hibino, Toshihiko, Drescher, Edit, Sánchez-Bursón, Juan, Rettenbacher, Manfred, Bhatia, Girish, Gadve, Snehal, Shah, Chirag, Bakhle, Dhananjay

المصدر: Abstracts Accepted for Publication

الإتاحة: https://doi.org/10.1136/annrheumdis-2019-eular.2844Test

View record in BASE

6

دورية أكاديمية

Comparative clinical efficacy and safety of the proposed biosimilar ABP 710 with infliximab reference product in patients with rheumatoid arthritis

المؤلفون: Genovese, Mark C., Sanchez-Burson, Juan, Oh, MyungShin, Balazs, Eva, Neal, Jeffrey, Everding, Andrea, Hala, Tomas, Wojciechowski, Rafal, Fanjiang, Gary, Cohen, Stanley

المساهمون: Amgen

المصدر: Arthritis Research & Therapy ; volume 22, issue 1 ; ISSN 1478-6362

الإتاحة: https://doi.org/10.1186/s13075-020-2142-1Test

View record in BASE

7

دورية أكاديمية

Patient-reported outcomes from a randomised phase III study of baricitinib in patients with rheumatoid arthritis and an inadequate response to biological agents (RA-BEACON)

المؤلفون: Smolen, Josef S., Kremer, Joel M., Gaich, Carol L., DeLozier, Amy M., Schlichting, Douglas E., Xie, Li, Stoykov, Ivaylo, Rooney, Terence, Bird, Paul, Sanchez Burson, Juan Miguel, Genovese, Mark C., Combe, Bernard

المساهمون: Smolen, Josef S. Med Univ Vienna, Vienna, Austria, Smolen, Josef S. Hietzing Hosp, Vienna, Austria, Kremer, Joel M. Albany Med Coll, Albany, NY 12208 USA, Gaich, Carol L. Eli Lilly & Co, Indianapolis, IN 46285 USA, DeLozier, Amy M. Eli Lilly & Co, Indianapolis, IN 46285 USA, Schlichting, Douglas E. Eli Lilly & Co, Indianapolis, IN 46285 USA, Xie, Li Eli Lilly & Co, Indianapolis, IN 46285 USA, Stoykov, Ivaylo Eli Lilly & Co, Indianapolis, IN 46285 USA, Rooney, Terence Eli Lilly & Co, Indianapolis, IN 46285 USA, Bird, Paul Univ New South Wales, Sydney, NSW, Australia, Sanchez Burson, Juan Miguel Valme Univ Hosp, Div Rheumatol, Seville, Spain, Sanchez Burson, Juan Miguel Valme Univ Hosp, Div Ophthalmol, Seville, Spain, Sanchez Burson, Juan Miguel Valme Univ Hosp, Div Immunol, Seville, Spain, Genovese, Mark C. Stanford Univ, Med Ctr, Palo Alto, CA 94304 USA, Combe, Bernard Univ Montpellier, Lapeyronie Hosp, Montpellier, France, Eli Lilly and Company, Incyte Corporation